featured
Aromatase Inhibitors With or Without an LH-RH Agonist Is an Effective Option for HR+ Male Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer (Tokyo, Japan)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Aromatase Inhibitors With or Without Luteinizing Hormone-Releasing Hormone Agonist for Metastatic Male Breast Cancer: A Report of Four Cases and Review of the Literature
Breast Cancer 2016 Nov 01;23(6)945-949, S Kuba, M Ishida, M Oikawa, Y Nakamura, K Yamanouchi, E Tokunaga, K Taguchi, T Esaki, S Eguchi, S OhnoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.